Someit Sidhu, Zura Bio CEO
June 17, 2022 09:43 AM EDTUpdated 05:11 PM
Financing

SPAC deal touch­es down for mi­cro­cap biotech armed with a PhII, for­mer Pfiz­er mon­o­clon­al an­ti­body

Paul Schloesser

Associate Editor

While SPACs have been go­ing slow af­ter the mar­ket’s per­for­mance so far, it hasn’t kept every­one away from deal­mak­ing and merg­ers.

A SPAC go­ing by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times